The pandemic caused by SARS-CoV-2 is currently representing a major health and economic threat to humanity. So far, no specific treatment to this viral infection has been developed and the emergency still requires an efficient intervention. In this work, we used virtual screening to facilitate drug repurposing against SARS-CoV-2, targeting viral main proteinase and spike protein with 3000 existing drugs. We used a protocol based on a docking step followed by a short molecular dynamic simulation and rescoring by the Nwat-MMGBSA approach. Our results provide suggestions for prioritizing in vitro and/or in vivo tests of already available compounds.
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins / I. Maffucci, A. Contini. - In: JOURNAL OF PROTEOME RESEARCH. - ISSN 1535-3893. - 19:11(2020), pp. 4637-4648. [10.1021/acs.jproteome.0c00383]
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
A. Contini
Ultimo
2020
Abstract
The pandemic caused by SARS-CoV-2 is currently representing a major health and economic threat to humanity. So far, no specific treatment to this viral infection has been developed and the emergency still requires an efficient intervention. In this work, we used virtual screening to facilitate drug repurposing against SARS-CoV-2, targeting viral main proteinase and spike protein with 3000 existing drugs. We used a protocol based on a docking step followed by a short molecular dynamic simulation and rescoring by the Nwat-MMGBSA approach. Our results provide suggestions for prioritizing in vitro and/or in vivo tests of already available compounds.File | Dimensione | Formato | |
---|---|---|---|
MS_covid19_29_08_20_postprint.pdf
accesso aperto
Descrizione: post print
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
1.25 MB
Formato
Adobe PDF
|
1.25 MB | Adobe PDF | Visualizza/Apri |
acs.jproteome.0c00383.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
5.3 MB
Formato
Adobe PDF
|
5.3 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.